Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Albireo Pharma Inc (NQ: ALBO )

35.08 USD -1.60 (-4.36%)
Official Closing Price Updated: 5:56 PM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Albireo Pharma Inc

< Previous 1 2 3 4 Next >
Albireo Enrolls First Patient in Phase 3 Clinical Trial of Odevixibat in Biliary Atresia
From GlobeNewswire News Releases
Albireo to Host Key Opinion Leader Call on Clinical Outcome Assessments
From GlobeNewswire News Releases
Albireo Announces Two Financing Transactions to Extend Cash Runway Into the Beginning of 2022
From GlobeNewswire News Releases
Albireo to Present at 2020 Jefferies Virtual Healthcare Conference
From GlobeNewswire News Releases
Albireo Reports Q1 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Albireo to Report First Quarter 2020 Financial Results on May 7
Conference call and webcast to be held at 10:00 a.m. ET 
From GlobeNewswire News Releases
Albireo to Present at 19th Annual Needham Healthcare Conference
From GlobeNewswire News Releases
Albireo Completes Enrollment in Phase 2 Study of Elobixibat in NASH/NAFLD
From GlobeNewswire News Releases
Albireo Reports Fourth Quarter and Year-End 2019 Financial Results, and Provides Business Update
From GlobeNewswire News Releases
Albireo Recognizes Rare Disease Day and Supports Global Effort to “Reframe Rare” By Highlighting the Challenges of Cholestatic Liver Disorders
From GlobeNewswire News Releases
Albireo to Present at Cowen and Company 40th Annual Health Care Conference
From GlobeNewswire News Releases
Albireo to Report Fourth Quarter and Year-End 2019 Financial Results on March 2
Conference call and webcast to be held at 10:00 a.m. ET 
From GlobeNewswire News Releases
NetworkNewsBreaks – Albireo Pharma, Inc. (NASDAQ: ALBO) Featured in ROTH Equity Research Report
From InvestorBrandNetwork
Albireo Announces Closing of $46 Million Public Offering Including Exercise in Full of Underwriters’ Option to Purchase Additional Shares
From GlobeNewswire News Releases
Albireo Prices $40 Million Public Offering of Common Stock
From GlobeNewswire News Releases
Albireo Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
Albireo Achieves Significant Milestones for Odevixibat Across Multiple Diseases
From GlobeNewswire News Releases
Albireo Joins with Alagille Syndrome Community in Celebrating First International Awareness Day
Alagille syndrome community advocates for education and resources with first-ever disease awareness day. 
From GlobeNewswire News Releases
Albireo to Present at the Jefferies 2019 London Healthcare Conference
From GlobeNewswire News Releases
Albireo Reports Third Quarter 2019 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Albireo Appoints Michelle Graham as Chief Human Resources Officer
Senior leader with demonstrated experience building high-performing businesses and teams 
From GlobeNewswire News Releases
Albireo to Report Third Quarter 2019 Financial Results on November 6, 2019
— Conference call and webcast to be held at 10:00 a.m. ET — 
From GlobeNewswire News Releases
Albireo Recognizes PFIC Awareness Day and Highlights Urgent Needs of Progressive Familial Intrahepatic Cholestasis Families
Grassroots PFIC community advocates to build awareness of rare, life-threatening liver disease 
From GlobeNewswire News Releases
Albireo Announces Presentations at NASPGHAN 2019 Annual Meeting
Presentations highlight data on odevixibat’s minimal systemic exposure and Albireo’s proprietary pruritus assessment tools 
From GlobeNewswire News Releases
Albireo to Participate in Upcoming Investor Conferences
From GlobeNewswire News Releases
Albireo Reports Second Quarter 2019 Financial Results
From GlobeNewswire News Releases
Albireo to Present at Wedbush PacGrow Healthcare Conference
From GlobeNewswire News Releases
Albireo to Report Second Quarter 2019 Financial Results and Host Conference Call and Webcast
From GlobeNewswire News Releases
Albireo Provides Mid-Year Clinical Development Update
Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, provided an update on the progress of the development of odevixibat... 
From GlobeNewswire News Releases
Albireo Announces Launch of “PFIC Voices”
Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the launch of PFIC Voices, a new global campaign to... 
From GlobeNewswire News Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback